Get startedLog in
    Picture of Novo Nordisk A/S logo

    NOVO B — Novo Nordisk A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapNeutral
    All News

    Brief: Novo Nordisk Introduces Updated Rybelsus® Tablet Formulation In Canada For Adults Living With Type 2 Diabetes

    Picture of Novo Nordisk A/S logoNovo Nordisk A/S
    09/06/2026 12:02
    BRIEF-Novo Nordisk Introduces Updated Rybelsus® Tablet Formulation In Canada For Adults Living With Type 2 Diabetes
    June 9 (Reuters) - Novo Nordisk A/S NOVOb.CO:
    • NOVO NORDISK INTRODUCES UPDATED RYBELSUS® TABLET FORMULATION IN CANADA FOR ADULTS LIVING WITH TYPE 2 DIABETES
    • NOVO NORDISK:  NEW DOSING OPTIONS ARE 1.5 MG, 4 MG AND 9 MG, COMPARED WITH 3 MG, 7 MG AND 14 MG IN ORIGINAL FORMULATION
    Source text: ID:nCNWB21nWa
    Further company coverage: [NOVOb.CO]

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Novo Nordisk A/S

    See all news